Literature DB >> 2667894

Tuftsin: its chemistry, biology, and clinical potential.

M Fridkin1, V A Najjar.   

Abstract

Tuftsin is a tetrapeptide, Thr-Lys-Pro-Arg, which resides in the Fc-domain of the heavy chain of immunoglobulin G. The peptide originates from a specific fraction of the parent protein through enzymatic processing. Tuftsin possesses a broad spectrum of activities related primarily to the immune system function and exerts on phagocytic cells, notably on macrophages. These include potentiation of various cell functions such as phagocytosis, motility, immunogenic response, and bactericidal and tumoricidal activities. The features of tuftsin, coupled with its low toxicity, make the peptide an attractive candidate for immunotherapy. Tuftsin's capacity to augment cellular activation is mediated by specific receptors that were identified, characterized, and recently isolated from rabbit peritoneal granulocytes. Tuftsin has been chemically synthesized by a variety of techniques, some of which are adequate for large-scale preparations. A multitude of analogs have also been synthesized and extensively studied for structure-function relationships.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667894     DOI: 10.3109/10409238909082550

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  17 in total

1.  The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats.

Authors:  I I Kozlovskii; N D Danchev
Journal:  Neurosci Behav Physiol       Date:  2003-09

2.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

3.  Augmentation of antileishmanial efficacy of miltefosine in combination with tuftsin against experimental visceral leishmaniasis.

Authors:  Nishi Shakya; Shraddha A Sane; Wahajul Haq; Suman Gupta
Journal:  Parasitol Res       Date:  2012-03-06       Impact factor: 2.289

4.  Local and systemic effects of an acute inflammation on eicosanoid generation capacity of polymorphonuclear cells and macrophages.

Authors:  J Mathieu; M Tissot; D Nolibe; I Florentin; J F Kergonou; J P Giroud
Journal:  Int J Exp Pathol       Date:  1990-10       Impact factor: 1.925

5.  Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.

Authors:  Anirudh Gairola; Aaron Benjamin; Joshua D Weatherston; Jeffrey D Cirillo; Hung-Jen Wu
Journal:  Adv Ther (Weinh)       Date:  2022-03-09

6.  Muramyldipeptide and granulocyte-macrophage colony-stimulating factor enhance interferon-gamma-induced nitric oxide production by rat alveolar macrophages.

Authors:  P G Jorens; F J van Overveld; H Bult; P A Vermeire; A G Herman
Journal:  Agents Actions       Date:  1993-01

7.  Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.

Authors:  T Bashi; O Shovman; M Fridkin; A Volkov; I Barshack; M Blank; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2016-02-04       Impact factor: 4.330

8.  C-reactive protein (CRP) peptides inactivate enolase in human neutrophils leading to depletion of intracellular ATP and inhibition of superoxide generation.

Authors:  E G Shephard; R Anderson; O Rosen; M Fridkin
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

9.  Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1.

Authors:  Jillian C Nissen; Stella E Tsirka
Journal:  Glia       Date:  2016-02-16       Impact factor: 7.452

10.  Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.

Authors:  Muzhou Wu; Jillian C Nissen; Emily I Chen; Stella E Tsirka
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.